Parkinson’s disease is rising faster than any other major brain disorder, yet a growing body of research argues that much of ...
Rotigotine 2 mg/24 hours, 4 mg/24 hours, 6 mg/24 hours; transdermal patch; contains sulfites. Neupro is a transdermal patch containing rotigotine, a D3/D2/D1 dopamine agonist. The mechanism of action ...
Roche RHHBY announced that it will advance pipeline candidate prasinezumab into phase III development for early-stage Parkinson’s disease. Roche has a licensing agreement with Prothena PRTA for ...
Tracking brain connectivity to predict the spread of Parkinson's disease is the focus of a study conducted by the neuroimaging unit at IRCCS San Raffaele in Milan, Italy, led by Massimo Filippi. The ...